Skip to main content
Download PDF

Volume 3 Supplement 2

30th Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2015)

Validation of multiplex immunofluorescence for use in analysis of tumour infiltrating lymphocytes

Journal for ImmunoTherapy of Cancer volume 3, Article number: P411 (2015) Cite this article

Background

Multiplexed immunohistochemistry (IHC) has the potential to improve conventional IHC staining allowing for analysis of multiple cell phenotypes while maintaining spatial context. Automated multispectral image analysis and computer-based cell recognition make the process more attainable, but stringent validation of multiplex IHC is still required. Pertinently, multiplex IHC allows for the characterisation and enumeration of immune cell densities in the tumour micro-environment, of particular importance for analysis of tumour-infiltrating immune cells which require multiple co-localised markers for their identification. However, issues of antibody blocking, cross-reactivity and masking have caused concern that the results of multiplex staining may not accurately reflect those of single-plex staining. The Opal workflow from PerkinElmer uses a heat-induced epitope retrieval step between each antibody detected which aims to obviate these potential problems and enable single-species antibody use. In this study we systematically validated multiplex staining for a range of immune cell markers against single-plex staining for each marker to determine the accuracy of the multiplex method.

Methods

Validation of multiplex IHC was undertaken using a multi-tissue TMA stained in multiplex for CD3, CD4, CD56 and CD20 in a 4-marker validation and for CD3, CD4, CD8, CD20 and FOXP3 in a 5-marker validation. The TMA was composed of 72 cores including normal lung, pancreas, breast, prostate and stomach and malignant prostate, lung and colon. Spearman correlations measured agreement of immune cell populations with those of singly stained serial sections on a per-core basis. Single-stain/single-stain comparisons of corresponding immune cell populations provided baseline variation of immune cells in subsequent sections.

Results

All validation comparisons showed a highly significant correlation (P < 0.0001) with strong correlation was observed between cores for the majority of multiplex stains. Specifically, for the 4-plex experiment, a high degree of correlation was observed for CD3, CD8 and CD20 with R2 of 0.835, 0.950 and 0.870 respectively (P= < 0.001); CD56 showed a lower degree of correlation between the multiplex and single stains with an R2 of 0.584 (P < 0.0001). For the 5-plex experiment, a high degree of correlation was observed for high degree of correlation for CD3, CD8 and CD20 with R2 of 0.87, 0.95 and 0.87 respectively (P < 0.0001). FOXP3 showed a poor correlation of 0.74 and CD4 showed a poor correlation of 0.58 (P < 0.0001).

Conclusion

Multiplex IHC is comparable to single stain IHC preserving precious samples and reagents while enhancing the information gained.

Author information

Authors and Affiliations

  1. The Medical School, The University of Manchester, Manchester, UK

    Henry Galetta

  2. PerkinElmer, Inc., Hopkinton, MA, USA

    James Mansfield

  3. Department of Histopathology, Manchester Royal Infirmary, Central Manchester University Hospitals NHS Trust, Manchester, UK

    Byers Richard

  4. Institute of Cancer Sciences, The University of Manchester, Manchester, UK

    Kenneth K Oguejiofor

Authors
  1. Henry Galetta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James Mansfield
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Byers Richard
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kenneth K Oguejiofor
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Galetta, H., Mansfield, J., Richard, B. et al. Validation of multiplex immunofluorescence for use in analysis of tumour infiltrating lymphocytes. j. immunotherapy cancer 3 (Suppl 2), P411 (2015). https://doi.org/10.1186/2051-1426-3-S2-P411

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/2051-1426-3-S2-P411

Keywords

  • Tumour Infiltrate Lymphocyte
  • Multispectral Image
  • Immune Cell Population
  • Multiplex Method
  • Stringent Validation